您要查找的是不是:
- Bisphosphonate treatment is also recommended. 另外,也建議進行雙磷酸鹽治療;
- Bisphosphonate have bone-seeking affinity,some of them are used as drugs for osteoporosis. 雙膦酸鹽有趨骨性並有抗骨質疏鬆症活性。
- The cross-linkage of Lead ions by bridging diphosphonate ligands resulted in a< 200> organic-inorganic hybrid layer. 化合物中;鉛通過橋連二膦酸配體形成一個有機無機雜化層;層與層之間通過范德華力相連形成超分子結構。
- In order to search for bone? targeted leading compounds with high affinity and low toxicity, seven steroid? bisphosphonate compounds were synthesized. 本文設計合成了7個甾體?膦酸酯偶合物,希望新化合物既有趨骨性又有協同抗骨質疏鬆作用,能得到療效好副作用小的骨靶向化合物的先導物。
- In drug treatment, calcitonin, bisphosphonate (alendronate), HRT (Livial), vitamins D2 and D3, and calcium are indicated. 在藥物治療方面,降鈣素、激素替代療法(利維愛等)、雙磷酸鹽(福善美等)、維生素D2、維生素D3及鈣劑都是適用的。
- Common bisphosphonate medications include alendronate (Fosamax(R)), ibandronate (Boniva(R)), risedonate (Actone(R)) and zoledronic acid (Reclast(R)). 常用的二膦酸鹽化合物類治療藥物包括阿倫膦酸鹽,伊班膦酸鹽,利賽膦酸鹽以及唑來膦酸。
- METHODS:To give account of research progress of diphosphonate preparations and to evaluate their application in some diseases. 方法:介紹雙膦酸鹽類藥物的研究進展,對其在一些疾病中的應用進行了評價。
- Dental treatments and procedures that require bone healing should be completed before initiating intravenous bisphosphonate therapy. 在開始靜脈注射雙磷酸鹽之前,應該完成需要骨頭痊癒的牙科治療程序。
- Many experts now informally advocate a bisphosphonate therapy holiday after 5 years of use in an effort to avoid these fractures. 目前許多專家建議在雙膦酸鹽治療5年後暫時停用一段時間以避免這類骨折的發生,當然這種做法是非正式的,還有待證實。
- Although no cause and effect relationship between bisphosphonate therapy and osteonecrosis has been established, it is suspected. 儘管使用雙磷酸鹽和骨壞死之間的因果聯繫還沒有建立,人們懷疑它們之間有因果聯繫。
- Importance of calcium co-medication in bisphosphonate therapy of osteoporosis: an approach to improving correct intake and drug adherence. 鈣的重要性的共同藥物雙膦酸鹽治療骨質疏鬆症:一個正確的方法來提高攝入量和藥物遵守。
- Androgen depriation therapy inoles reducing hormones such as testosterone that encourage cancer growth. Alendronate, a bisphosphonate, is best known as an anti-osteoporosis drug. 雄激素剝脫療法包括降低如睾酮等促進腫瘤生長的激素。阿倫膦酸鹽,一種二磷酸鹽,是已知的抗骨質疏鬆藥物。
- The aim of the present study was to determine and describe the radiographic features associated with cyclical bisphosphonate therapy in the growing skeleton. 本研究旨在明確與雙膦酸鹽類藥物用於治療骨骼未發育成熟兒童相關的影像學特徵。
- Objective To study the influence of methylene diphosphonate (MDP) upon bone 99 Tc m MDP uptake in mice in order to provide experimental and theoretical basis for using of "Yunke" in treatment of rheumatoid arthritis. 目的 為臨床應用99Tc 亞甲基二膦酸鹽 (99Tc MDP ,「雲克」)治療類風濕疾病提供實驗和理論依據。
- There's no data on bisphosphonate use in patients on anticonvulsants, so I'd just have a high index of suspicion and make sure you're giving them good vitamin D therapy,」 he continued. 目前尚無有關雙膦酸鹽用於接收了抗驚厥治療的患者的資料,因此現在只能高度關注,同時確保患者接受了足夠的維生素D治療。」
- 99mTc medronate methylene diphosphonate 99m鍀甲烯亞甲基二磷酸鹽
- MDP(disodium methylene diphosphonate) 甲撐二磷酸二氫二鈉
- dichloromethylene diphosphonate(Cl-2MDP) [化] 二氯亞甲基二膦酸
- diisopropylmethylene diphosphonate 二異丙基亞甲基二磷酸鹽, 或酯
- disodium methylene diphosphonate 亞甲基雙磷酸氫鈉, 甲撐二磷酸二氫二鈉